Models for Predicting Effective HIV Chemoprevention in WomenMelanie R. Nicol, Angela D. M. Kashuba, Cindi W. Emerson et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2014Cited by 21
Immunologic, Virologic, and Pharmacologic Characterization of the Female Upper Genital Tract in HIV-Infected WomenLisa Rahangdale, Myron S. Cohen, Angela D. M. Kashuba et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2014Cited by 8
Oral Maraviroc and Tenofovir for HIV Prevention in Women: An <i>Ex Vivo</i> and Translational ApproachMelanie R. Nicol, Angela D. M. Kashuba, Heather MA Prince et al.|AIDS Research and Human Retroviruses|2014Cited by 0
Immunologic, Virologic, and Pharmacologic Characterization of the Female Upper Genital Tract in HIV-Infected WomenCindi W. Emerson, Trenton Stevens, Lisa Rahangdale et al.|UNC Libraries|2020Cited by 0
Models for Predicting Effective HIV Chemoprevention in WomenKristine B. Patterson, Cindi W. Emerson, Yuri Fedoriw et al.|UNC Libraries|2020Cited by 0